BETA Startup Showcase: Thaddeus Medical

by Valerie Lockhart

BETA Startup: Thaddeus Medical LogoThe TECHdotMN team would like to introduce you to each of the startups featured in the upcoming BETA showcase. Over the next couple of weeks, we will highlight each company, so you can get a better idea of the talent, hardwork, and dedication held within each of these startups.

The next company in our BETA Startup Showcase series is: Thaddeus Medical

Protecting temperature sensitive medical products in transit through smart, reusable packaging.

Tell us the story of how and why you started your company.
I learned about the serious harm to patients that can occur through the improperly controlling and tracking temperature of clinical specimens while I was a Research Associate at Mayo Clinic. As Mayo has outstanding protocols to protect patients, they reject / refuse to test specimens if they are not received at the appropriate temperature. As medical errors are the 3rd biggest killer in the US, it is not unreasonable to think that this is sometimes overlooked at other hospitals especially outside the United States. If there was a better way to control and track temperature for individual clinical specimens, there would be a lot less risk to harming the patient. The same is true for therapeutics, with all the biological therapies that are being sent to patients homes, a solution is needed to protect the therapeutics and provide a better experience to the patient.

What’s your most recent success or milestone hit?
We have DEMO units!!! Fill out the form on our website if your Hospital or Pharmacy would like to try it: Thaddeus Med

Where do you see your startup in 1 year?
Hopefully no longer a startup, but 3rd party tested and approved moving also into the transportation and storage of transplanted organs.

Get your tickets for the BETA Showcase tonight!

BETA Startup Showcase: LEAH Labs

by Valerie Lockhart

Categories

BETA Startup: LEAH Labs LogoThe TECHdotMN team would like to introduce you to each of the startups featured in the upcoming BETA showcase. Over the next couple of weeks, we will highlight each company, so you can get a better idea of the talent, hardwork, and dedication held within each of these startups.

The next company in our BETA Startup Showcase series is: LEAH Labs

LEAH Labs is working towards a cure for cancer in dogs with gene editing and CAR-T cell therapy.
Read More »

BETA Startup Showcase: SupDoc

by Valerie Lockhart

BETA Startup: SupDoc LogoThe TECHdotMN team would like to introduce you to each of the startups featured in the upcoming BETA showcase. Over the next couple of weeks, we will highlight each company, so you can get a better idea of the talent, hardwork, and dedication held within each of these startups.

The next company in our BETA Startup Showcase series is: SupDoc

SupDoc is a messaging-based, direct-to-consumer virtual health app that empowers on-the-go users to ditch the complicated health system and get efficient care anywhere
Read More »

BETA Startup Showcase: Anatomi

by Valerie Lockhart

Categories

BETA Startup: Anatomi Logo
The TECHdotMN team would like to introduce you to each of the startups featured in the upcoming BETA showcase. Over the next couple of weeks, we will highlight each company, so you can get a better idea of the talent, hardwork, and dedication held within each of these startups.

The third featured company in our BETA Startup Showcase series is: Anatomi

Read More »

New Minnesota-based Fund has $225 Million to Invest in Young Med-tech Companies

sourced

Via the Star Tribune

“Two longtime West Coast investors in medical technology, Kirk Nielsen and Dr. Justin Klein, have joined to launch a new firm in Minnesota called Vensana Capital. Despite the challenging environment facing early-stage med-tech companies, Vensana announced this month that its inaugural fund, Vensana Capital I, has attracted $225 million in committed capital with plans to invest in a dozen or so medical-technology companies. “

Read more…

U of M Startup Anatomi Corp. Developing Technology to Accelerate Discovery of Neurological Therapeutics

sourced

Categories

Via News Release

MINNEAPOLIS/ST. PAUL (08/26/19) – The University of Minnesota today announced the recent launch of Anatomi Corp., a startup company based on University technology that promotes the discovery of new treatments for neurological diseases such as Alzheimer’s, Parkinson’s and ALS.

Read More »

Life Epigenetics Releases Open Source Software to Advance Epigenetics Research

sourced

Categories

Via News Release

MINNEAPOLISAug. 26, 2019 /PRNewswire/ — Life Epigenetics, LLC a subsidiary of GWG Holdings, Inc.  announced the release of two Python open source software packages to epigenetics researchers worldwide. This software will facilitate scientific breakthroughs by accelerating and simplifying the processing of complex epigenetic data that researchers use to advance their understanding of this rapidly evolving science.

Read More »

Minnesota’s CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device

sourced

Categories

Via News Release

CVRxMINNEAPOLISAug. 16, 2019 /PRNewswire/ — CVRx, Inc., a private medical device company, announced today that it has received Premarket Approval (PMA) from the United States Food and Drug Administration (FDA) to market its BAROSTIM NEO device for heart failure in the United States. The FDA’s Center for Devices and Radiological Health (CDRH) approved the Company’s submission after a thorough review of the clinical trial data from the Baroreflex Activation Therapy for Heart Failure Pivotal Trial (BeAT-HF).

Read More »

POPS! Diabetes Care Announces Closing of Oversubscribed Series A Funding

by Valerie Lockhart

Categories

Image result for pops diabetes care logoThe team at POPS! Diabetes Care, Inc. has plenty of reason to celebrate this summer. They recently closed an oversubscribed Series A funding of $6 Million, with incredible investor demand. Their product, a digital system which allows users to track and manage their A1C and insulin levels through an app and connected monitoring device, is making major waves in the healthcare space. FDA approval was reached in November of 2018, and in preliminary clinical research, their product demonstrated a 1-point drop in overall A1C for users.

Read More »

International Cardio Corporation Achieves First Human Use of Its Noninvasive HIFU Treatment for Peripheral Vascular Disease

sourced

Categories

Via News Release

Image result for International Cardio CorporationMINNEAPOLIS–(BUSINESS WIRE)–International Cardio Corporation (ICC) announced today that it has achieved the first human use milestone of its HIFU Synthesizer™, a therapeutic ultrasound system designed to noninvasively treat vulnerable and occlusive plaques in peripheral arteries. The first of a fifteen patient Safety Study in the Netherlands, this achievement supports the company’s core objectives to reduce stroke mortality and improve the quality of life for those suffering from peripheral vascular disease (PVD).

Read More »

Post Navigation